China SXT Pharmaceuticals, Inc. Depreciation and Amortization
China SXT Pharmaceuticals, Inc. (SXTC) reported Depreciation and Amortization of $73.67 thousand for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-07-01
| Period end | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|
| 2026-03-31 | $73.67K 20-F · filed 2026-07-01 | |
| 2025-09-30 | $32.10K 6-K · filed 2025-12-31 | |
| 2025-03-31 | $82.30K 20-F · filed 2026-07-01 | |
| 2024-09-30 | $68.54K 6-K · filed 2025-12-31 | |
| 2024-03-31 | $203.25K 20-F · filed 2026-07-01 | |
| 2023-09-30 | $102.75K 6-K · filed 2025-03-28 | |
| 2023-03-31 | $250.16K 20-F · filed 2025-07-31 | |
| 2022-09-30 | $109.97K 6-K · filed 2024-04-05 | |
| 2022-03-31 | $320.01K 20-F · filed 2024-08-13 | |
| 2021-03-31 | $345.41K 20-F · filed 2023-07-31 | |
| 2020-03-31 | $331.84K 20-F/A · filed 2023-05-19 | |
| 2019-03-31 | $180.92K 20-F · filed 2021-08-13 | |
| 2018-03-31 | $129.44K 20-F · filed 2020-07-31 |